Biotech IPO Market Wavers As 2 Postpone, 1 Falls Short
Biotech firms eyeing initial public offerings are having another bumpy week, with two companies again postponing their public debuts as a third fell flat Thursday, suggesting that investors may be getting...To view the full article, register now.
Already a subscriber? Click here to view full article